TredegarBioceres

Tredegar vs Bioceres

Specialty polymer films manufacturer focused on packaging and healthcare vs Latin American agricultural biotech firm developing crop traits. Which is the better buy for your portfolio in June 2026? Plain-English answer below.

Tredegar produces aluminum rolling products and specialty films for packaging, personal care, and industrial applications, operating as a legacy industrial manufacturer that's navigated restructuring ...

Investment Analysis

Pros

  • Tredegar reported a significant sales increase in Q3 2025, driven by higher volumes and improved pricing in its Aluminum Extrusions segment.
  • Gross margin expanded to 16.0% in Q3 2025, reflecting improved operational efficiency and favourable market conditions.
  • Liquidity strengthened with higher cash balances, reduced revolver borrowings, and increased availability under its ABL facility.

Considerations

  • Tredegar posted a full-year net loss in 2024, indicating ongoing profitability challenges despite recent quarterly improvements.
  • The company's earnings remain volatile, with net income from continuing operations fluctuating significantly between quarters.
  • Tredegar's reliance on cyclical industries such as construction and automotive exposes it to macroeconomic downturns and commodity price swings.

Pros

  • Bioceres Crop Solutions offers a diversified portfolio of crop productivity solutions across seeds, crop protection, and nutrition, supporting multiple revenue streams.
  • The company's HB4 drought-tolerant seed technology provides a unique competitive advantage in water-stressed agricultural regions.
  • Bioceres operates internationally, with a strong presence in key agricultural markets including Argentina, Brazil, and North America.

Considerations

  • Bioceres has a low price-to-book ratio and negative P/E, suggesting market concerns about its profitability and future earnings potential.
  • The company's interest coverage ratio is below one, indicating limited ability to service its debt obligations from operating earnings.
  • Bioceres faces regulatory and environmental risks associated with agricultural chemicals and genetically modified seed technologies.

Buy TG or BIOX in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

TG
TG$8.19
vs
BIOX
BIOX$0.00
Buy TG